CHARLES RIVER LABORATORIES GROUP

SC198206
Active East Lothian

Dormant Company

1,994 employees website.com
Life sciences and medical technology Dormant Company
C

CHARLES RIVER LABORATORIES GROUP

SC198206

Dormant Company

Founded 19 Jul 1999 Active East Lothian, United Kingdom 1,994 employees website.com
Life sciences and medical technology Dormant Company

Previous Company Names

INVERESK RESEARCH GROUP LIMITED 1 Sept 1999 — 24 Nov 2005
M M & S (2558) LIMITED 19 Jul 1999 — 1 Sept 1999
Accounts
Confirmation Submitted 1 Jul 2025 Next due 15 Jul 2026 14 days remaining
Net assets £113M
Total assets £167M
Total Liabilities £54M
Charges 5
5 satisfied

Contact & Details

Contact

Registered Address

Elpinstone Research Centre Tranent East Lothian EH33 2NE

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CHARLES RIVER LABORATORIES GROUP (SC198206), an active life sciences and medical technology company based in East Lothian, United Kingdom. Incorporated 19 Jul 1999. Dormant Company. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2004
Type group
Next accounts
Due by

Balance Sheet & P&L (2004–2004)

Cash in Bank

£11.04M

Net Assets

£112.93M

Total Liabilities

£54.28M

Turnover

£111.56M

Employees

1994

Debt Ratio

32%

Financial History

Revenue, profit, EBITDA and key financial figures

2004
31 Dec Year End
P&L
Revenue
£142.3M
Gross Profit
£48.2M
Operating Profit
£22.4M
Net Profit
£18.1M
EBITDA
£31.5M
Assets
Cash
£24.7M
Total Assets
£89.4M
Liabilities
Total Liabilities
£45.2M
Key Metrics
Employees
1,247
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Rushna Tejani HeneghanSecretaryUnknownUnknown1 Jan 2021Active

Shareholders

Shareholders (1)

Charles River Laboratories Luxembourg
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Charles River Laboratories Luxembourg Sarl

Unknown

Active
Notified 1 May 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent

Group Structure

Group Structure

No group structure identified

Charges

Charges

5 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
1 Jul 2025Confirmation StatementConfirmation statement made on 1 Jul 2025 with no updates
9 Jul 2024Confirmation StatementConfirmation statement made on 8 Jul 2024 with no updates
10 Aug 2023Confirmation StatementConfirmation statement made on 8 Jul 2023 with no updates
11 Aug 2022Confirmation StatementConfirmation statement made on 8 Jul 2022 with no updates
27 Jun 2022OfficersTermination of David Ross Smith as director on 24 Jun 2022
1 Jul 2025 Confirmation Statement

Confirmation statement made on 1 Jul 2025 with no updates

9 Jul 2024 Confirmation Statement

Confirmation statement made on 8 Jul 2024 with no updates

10 Aug 2023 Confirmation Statement

Confirmation statement made on 8 Jul 2023 with no updates

11 Aug 2022 Confirmation Statement

Confirmation statement made on 8 Jul 2022 with no updates

27 Jun 2022 Officers

Termination of David Ross Smith as director on 24 Jun 2022

Recent Activity

Latest Activity

Confirmation statement made on 1 Jul 2025 with no updates

12 months ago on 1 Jul 2025

Confirmation statement made on 8 Jul 2024 with no updates

1 years ago on 9 Jul 2024

Confirmation statement made on 8 Jul 2023 with no updates

2 years ago on 10 Aug 2023

Confirmation statement made on 8 Jul 2022 with no updates

3 years ago on 11 Aug 2022

Termination of David Ross Smith as director on 24 Jun 2022

4 years ago on 27 Jun 2022